Jakob W. Gotfredsen
Keine laufenden Positionen mehr
Karriereverlauf von Jakob W. Gotfredsen
Ehemalige bekannte Positionen von Jakob W. Gotfredsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neurokey A/S
Neurokey A/S Pharmaceuticals: MajorHealth Technology Neurokey wants to become a leading drug development company in the critical care field. The drugs under development will one day help countless patients suffering from the effects of debilitating and potentially fatal cardiovascular and neurological; diseases. Neurokey will be first to market with reliable efficient and easily administered medication that will increase the survival rate for these patients and dramatically minimize the risk of permanent neurological damage. | Gründer | 15.04.2010 | 30.07.2010 |
Corporate Officer/Principal | 07.07.2009 | 30.07.2010 | |
Präsident | 01.01.2007 | 07.07.2009 | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
Ausbildung von Jakob W. Gotfredsen
University of Copenhagen | Masters Business Admin |
Statistik
International
Dänemark | 3 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 2 |
Founder | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Neurokey A/S
Neurokey A/S Pharmaceuticals: MajorHealth Technology Neurokey wants to become a leading drug development company in the critical care field. The drugs under development will one day help countless patients suffering from the effects of debilitating and potentially fatal cardiovascular and neurological; diseases. Neurokey will be first to market with reliable efficient and easily administered medication that will increase the survival rate for these patients and dramatically minimize the risk of permanent neurological damage. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Börse
- Insiders
- Jakob W. Gotfredsen
- Erfahrung